Jinhe Biotechnology Co., Ltd. is a listed company specialized in producing veterinary medicines. After over 25 years’ development, it is today a world leader in various specifications and kinds of Chlortetracycline with an annual yield of 55000 tons and the products as Chlortetracycline Hydrochloride and Salinomycin also rank in front of the industry.

There are advanced fermentation and test equipments in the production area and all the manufacturing process is automatically controlled by computer system. Now the company has a fermention capacity of5800m3which ranks in front in today’s world.

The company passed the US FDA inspection for the first time in 1994 (vmf 5468) and re-inspections in 1997, 2000, 2007, 2010, 2014 and 2016 respectively. It also got China GMP, Europe COS and Japan FMA. Jinhe went public in July, 2012 (Stock code: 002688). In 2014, its wholly-owned subsidiary Pharmgate LLC acquired Pennfield Oil Company inUSA, making it smoothly penetrating market of animal health inUSA.

More than 60% of our products are exported toUSA, South-east Asia, Latin America and Europe etc, Zoetis (Pfizer)USAis our largest partner. We promise to provide our customers with high quality products, stable supply, quick response and good after-sales service. Warmly welcome friends worldwide to negotiate with us for our mutual benefits.